Rovsing (ROV) Q1 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 26/27 earnings summary
10 Nov, 2026Executive summary
Q1 revenue and EBITDA trailed expectations amid higher project-hour consumption, delays on ongoing projects and postponed customer decisions.
Galileo project completed and delivered; tender activity remained high, with DKK 150m of outstanding tenders.
Financial highlights
Q1 revenue was DKK 2.6m versus DKK 7.3m in Q1 2025/26; Q1 EBITDA was DKK -2.7m versus DKK -0.6m.
Q1 order intake was DKK 5.9m and order backlog stood at DKK 21.6m at September 2026 end.
FY2025/26 revenue was DKK 30.8m and EBITDA DKK -3.5m; Kourou closing activity had a one-off DKK 0.9m effect.
Outlook and guidance
FY2026/27 guidance was maintained at DKK 27–34m revenue and DKK -4m to break-even EBITDA.
Several tender decisions are expected during FY2026/27, with new contract activities expected to begin in H2; conversion and delivery timing remain uncertain.
Latest events from Rovsing
- FY 2025/26 revenue reached DKK 30.8m, with a strong pipeline and positive sector outlook.ROV
Q4 25/26 - Q3 revenue and EBITDA improved; rights issue and ESA budget growth support future expansion.ROVQ3 25/26
- Leveraging record ESA budgets, the firm raises DKK 10.4m to fund growth and expand its order backlog.ROVInvestor presentation
- Revenue and EBITDA missed expectations, but backlog and tender activity remain strong.ROVQ2 25/26
- Revenue and EBITDA declined in Q1, but strong backlog and sector growth support a positive outlook.ROVQ1 25/26
- Stabilized revenue and EBITDA in 2024/25, with growth and acquisitions planned for 2025/26.ROVQ4 24/25
- Q1 revenue rose 17.3% year-over-year, with strong order intake and positive outlook.ROVQ1 24/25
- Q3 revenue and EBITDA declined, but a strong backlog and new contracts support a positive outlook.ROVQ3 24/25
- H1 2024/25 saw lower earnings and revised guidance, but expansion plans remain on track.ROVQ2 24/25